Cargando…

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease

BACKGROUND: Parkinson's disease (PD) is a complex disorder caused by genetic, environmental and age-related factors, and it is more prevalent in men. We aimed to identify differentially expressed genes in peripheral blood leukocytes (PBLs) that might be involved in PD pathogenesis. Transcriptom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kedmi, Merav, Bar-Shira, Anat, Gurevich, Tanya, Giladi, Nir, Orr-Urtreger, Avi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189133/ https://www.ncbi.nlm.nih.gov/pubmed/21943286 http://dx.doi.org/10.1186/1750-1326-6-66

Ejemplares similares

C9orf72-G(4)C(2) Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis
por: Kobo, Hila, et al.
Publicado: (2021)

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020)

A Personalized Approach to Parkinson’s Disease Patients Based on Founder Mutation Analysis
por: Giladi, Nir, et al.
Publicado: (2016)

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
por: Omer, Nurit, et al.
Publicado: (2021)

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021)

R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodies
por: Goldstein, Orly, et al.
Publicado: (2021)

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021)

Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease
por: Kozlovski, Tal, et al.
Publicado: (2019)

FUS-P525L Juvenile Amyotrophic Lateral Sclerosis and Intellectual Disability: Evidence for Association and Oligogenic Inheritance
por: Goldstein, Orly, et al.
Publicado: (2022)

Subthalamic Neurons Encode Both Single- and Multi-Limb Movements in Parkinson’s Disease Patients
por: Tankus, Ariel, et al.
Publicado: (2017)

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
por: Droby, Amgad, et al.
Publicado: (2022)

Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes
por: Zlotnik, Yair, et al.
Publicado: (2015)

Comparison of Selegiline and Rasagiline Therapies in Parkinson Disease: A Real-life Study
por: Peretz, Chava, et al.
Publicado: (2016)

Statin adherence and the risk of Parkinson's disease: A population-based cohort study
por: Rozani, Violetta, et al.
Publicado: (2017)

White Matter Hyperintensities in Parkinson’s Disease: Do They Explain the Disparity between the Postural Instability Gait Difficulty and Tremor Dominant Subtypes?
por: Herman, Talia, et al.
Publicado: (2013)

GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
por: Gan-Or, Ziv, et al.
Publicado: (2015)

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022)

Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease
por: Thaler, Avner, et al.
Publicado: (2022)

SPARC: a new approach to quantifying gait smoothness in patients with Parkinson’s disease
por: Beck, Yoav, et al.
Publicado: (2018)

Paroxysmal Slow-Wave Events Are Uncommon in Parkinson’s Disease
por: Milikovsky, Dan Z., et al.
Publicado: (2023)

Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study
por: Anis, Saar, et al.
Publicado: (2022)

Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation
por: Shkury, Eden, et al.
Publicado: (2023)

Subunit composition of α5-containing nicotinic receptors in the rodent habenula
por: Scholze, Petra, et al.
Publicado: (2012)

Effect of Rivastigmine on Mobility of Patients with Higher-Level Gait Disorder: A Pilot Exploratory Study
por: Gurevich, Tanya, et al.
Publicado: (2014)

Overnight Distribution of REM Sleep Features in People with Parkinson’s Disease (PD) and Non-PD Controls
por: Dagay, Andrew, et al.
Publicado: (2023)

Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older
por: Saiag, Esther, et al.
Publicado: (2023)

Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis
por: Giladi, Nir, et al.
Publicado: (2016)

Sensor-Based and Patient-Based Assessment of Daily-Living Physical Activity in People with Parkinson’s Disease: Do Motor Subtypes Play a Role?
por: Galperin, Irina, et al.
Publicado: (2020)

Higher-Level Cognitive Function and Obstacle Attributes: An fNIRS Study in Older Adults With Parkinson’s Disease
por: Hausdorff, Jeffrey, et al.
Publicado: (2020)

MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression
por: Kedmi, Merav, et al.
Publicado: (2015)

Automated detection of missteps during community ambulation in patients with Parkinson’s disease: a new approach for quantifying fall risk in the community setting
por: Iluz, Tal, et al.
Publicado: (2014)

Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for Treatment
por: Plotnik, Meir, et al.
Publicado: (2012)

FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage disease
por: Matthews, Dawn C., et al.
Publicado: (2018)

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients()()
por: Xu, Yaqian, et al.
Publicado: (2020)

Single-channel properties of α3β4, α3β4α5 and α3β4β2 nicotinic acetylcholine receptors in mice lacking specific nicotinic acetylcholine receptor subunits
por: Ciuraszkiewicz, Anna, et al.
Publicado: (2013)

P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease
por: Hauser, Robert A., et al.
Publicado: (2022)

Stepping up to meet the challenge of freezing of gait in Parkinson’s disease
por: Lewis, Simon, et al.
Publicado: (2022)

Gait festination in parkinsonism: introduction of two phenotypes
por: Nonnekes, Jorik, et al.
Publicado: (2018)

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
por: Veiga, Nuphar, et al.
Publicado: (2018)

A single-center real-life study on the use of medical cannabis in patients with dystonia
por: Anis, Saar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vbunl80ui3kqd3n0emn4ln6uua